Belgium vs India: Proportion of isolates with decreased susceptibility or resistance
Belgium
0.6
in 2020
India
0
in 2020
Belgium rank
10th
India rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Belgium
- India
How they compare
Belgium currently reports 0.6 against 0 in India, a difference of 0.6.
The two have swapped places 1 time across 10 shared years of data; in 2009 it was India ahead.
Belgium ranks 10th and India ranks 13th of 52 countries.
Across the 3 decades both report, Belgium averaged higher in 1 and India in 2.
Head to head by decade
| Decade | Belgium | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 10.81 | 10.81 | India |
| 2010s | 0 | 3.41 | 3.41 | India |
| 2020s | 0.6 | 0 | 0.6 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Belgium or India?
- Belgium, at 0.6 against 0 in India as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Belgium and India?
- 0.6, with Belgium ahead.
- How many years of comparable data are there for Belgium and India?
- 10 years are reported by both, from 2009 to 2020.
- How do Belgium and India rank globally for proportion of isolates with decreased susceptibility or resistance?
- Belgium ranks 10th and India ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.